Immunomedics, Inc.
IMMU
Odeh v. Immunomedics, Inc., No. 2:18-cv-17645 (D. N.J.)
This lawsuit alleges that Defendants made materially false and misleading statements and omissions about Immunomedics' receipt of and approach to handling a Form 483 from the Food and Drug Administration, which ultimately caused the Company's new drug application to fail.
Block & Leviton is co-lead counsel with Robbins, Geller, Rudman & Dowd LLP in this litigation.
The Court denied Defendants’ Motion to Dismiss on July 31, 2020. There is not yet a trial schedule in place.
Lead Plaintiff deadline
class period
August 23, 2018
to
December 20, 2018
